Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Exp: 12/15/2021 and Lot# AOD202
Bowel adhesion and research protocol with the stable gastric pentadecapeptide BPC 157, [PMID: 33251034] Laboratory literature summary: Bowel adhesion and research protocol with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine in rats
SYSTEMIC SUPPORT Unlike localized treatments, oral BPC-157 can provide systemic benefits, supporting overall integrity as it circulates through the body
the peptide layer is not FDA-approved for the uses we describe, and we keep that distinction clear when we plan a combined protocol
These targeting peptides recognize molecular signatures unique to MS lesions, including upregulated adhesion molecules on inflamed blood vessel walls and exposed myelin antigens in active plaques
